Home ›
Trademark Categories ›
Pharmaceuticals ›
2010 ›
TR ›
TRIPLEXAM
Trademark search for:
TRIPLEXAM
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2010-10-07 — Application filed
2010-11-25 — Sn assigned for sect 66a appl from ib
2010-11-29 — Application filed
2010-11-30 — Application filed
2010-12-04 — Application filed
2011-01-07 — Assigned to examiner
2011-01-10 — Approved for pub - principal register
2011-02-16 — Notice of publication
2011-03-03 — Notification of possible opposition sent to ib
2011-03-03 — Notice of start of opposition period created, to be sent to ib
2011-03-08 — Published for opposition
2011-05-24 — Registered-principal register
2011-06-23 — Grant of protection created, to be sent to ib
2011-08-04 — Final disposition recorded
2011-08-04 — Final disposition recorded
2011-10-02 — Notification processed by ib
2011-12-03 — Change of name/address rec'd from ib
2017-12-29 — Cancelled section 71
2018-08-29 — Total invalidation of reg ext protection created
2018-09-10 — Total invalidation of reg ext protection sent to ib
2018-09-10 — Invalidation processed
2018-12-15 — Total invalidation processed by the ib
2020-10-07 — Final status recorded
2021-11-27 — Death of international registration
2021-11-27 — Notification of effect of cancellation of intl reg mailed
2022-03-22 — Undeliverable mail - no action taken
Owner Information
BIOFARMA
FR
BIOFARMA
FR
BIOFARMA
FR
Correspondent
BIOFARMA 22 rue Garnier F-92200 NEUILLY-SUR-SEINE, FRANCE
Filing Details
Filing Date:
2010-10-07
Status Date:
2020-10-07
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.